🇺🇸 FDA
Patent

US 7208515

Diphenylmethyl compounds useful as muscarinic receptor antagonists

granted A61KA61K31/40A61K31/445

Quick answer

US patent 7208515 (Diphenylmethyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/40, A61K31/445, A61K9/0075, A61K9/0078